Value Partners Investments Inc. Eli Lilly & CO Transaction History

Value Partners Investments Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $3.9 Million - $5.16 Million	-29,896 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $2.8 Million - $3.23 Million	19,120 Added 177.43%	29,896 $4.43 Million
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $1.47 Million - $1.77 Million	10,776 New	10,776 $1.77 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $743B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Value Partners Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Value Partners Investments Inc. with notifications on news.